PIN66 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIA

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1307
https://www.valueinhealthjournal.com/article/S1098-3015(19)33685-X/fulltext
Title : PIN66 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33685-X&doi=10.1016/j.jval.2019.09.1307
First page :
Section Title :
Open access? : No
Section Order : 11142
Categories :
Tags :
Regions :
ViH Article Tags :